| Guillermo Novo | Chair and Chief Executive Officer | FY2024 | |
| J. Kevin Willis | SVP, Chief Financial Officer | FY2023 | |
| Osama M. Musa | SVP, Chief Technology Officer | FY2023 | |
| Alessandra Faccin Assis | SVP & GM Life Sciences & Intermediates | FY2024 | |
| James P. Minicucci | SVP & GM Personal Care | Not disclosed | — |
| Karl Bostaph | SVP, Operations | Not disclosed | — |
| William Whitaker | SVP and Chief Financial Officer | Not disclosed | — |
7 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.